Skip to main content

Development of novel radiotherapy technologies: spatially fractionated radiotherapy, charged particle therapy and use of nanoparticles as radio-sensitizers

RYC2018-024043-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Synchrotron-based infrared microspectroscopy unveils the biomolecular response of healthy and tumour cell lines to neon minibeam radiation therapy

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Seksek, Olivier|||0000-0002-3053-3022
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Bergs, J.
  • Hirayama, R.
  • Inaniwa, Taku
  • Matsufuji, N.
  • Shimokawa, Takashi|||0000-0001-6549-9277
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
Radioresistant tumours remain complex to manage with current radiotherapy (RT) techniques. Heavy ion beams were proposed for their treatment given their advantageous radiobiological properties. However, previous studies with patients resulted in serious adverse effects in the surrounding healthy tissues. Heavy ion RT could therefore benefit from the tissue-sparing effects of minibeam radiation therapy (MBRT). To investigate the potential of this combination, here we assessed the biochemical response to neon MBRT (NeMBRT) through synchrotron-based Fourier transform infrared microspectroscopy (SR-FTIRM). Healthy (BJ) and tumour (B16-F10) cell lines were subjected to seamless (broad beam) neon RT (NeBB) and NeMBRT at HIMAC. SR-FTIRM measurements were conducted at the MIRAS beamline of ALBA Synchrotron. Principal component analysis (PCA) permitted to assess the biochemical effects after the irradiations and 24 hours post-irradiation for the different RT modalities and doses. For the healthy cells, NeMBRT resulted in the most dissimilar spectral signatures from non-irradiated cells early after irradiations, mainly due to protein conformational modifications. Nevertheless, most of the damage appeared to recover one day post-RT; conversely, protein- and nucleic acid-related IR bands were strongly affected by NeBB 24 hours after treatment, suggesting superior oxidative damage and nucleic acid degradation. Tumour cells appeared to be less sensitive to NeBB than to NeMBRT shortly after RT. Still, after one day, both NeBB and the high-dose NeMBRT regions yielded important spectral modifications, suggestive of cell death processes, protein oxidation or oxidative stress. Lipid-associated spectral changes, especially due to the NeBB and NeMBRT peak groups for the tumour cell line, were consistent with reactive oxygen species attacks.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Investigating the biochemical response of proton minibeam radiation therapy by means of synchrotron-based infrared microspectroscopy

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Seksek, Olivier|||0000-0002-3053-3022
  • Ortiz, Ramon
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Juchaux, Marjorie
  • Nauraye, Catherine
  • Marzi, Ludovic De
  • Patriarca, Annalisa
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
The biology underlying proton minibeam radiation therapy (pMBRT) is not fully understood. Here we aim to elucidate the biological effects of pMBRT using Fourier Transform Infrared Microspectroscopy (FTIRM). In vitro (CTX-TNA2 astrocytes and F98 glioma rat cell lines) and in vivo (healthy and F98-bearing Fischer rats) irradiations were conducted, with conventional proton radiotherapy and pMBRT. FTIRM measurements were performed at ALBA Synchrotron, and multivariate data analysis methods were employed to assess spectral differences between irradiation configurations and doses. For astrocytes, the spectral regions related to proteins and nucleic acids were highly affected by conventional irradiations and the high-dose regions of pMBRT, suggesting important modifications on these biomolecules. For glioma, pMBRT had a great effect on the nucleic acids and carbohydrates. In animals, conventional radiotherapy had a remarkable impact on the proteins and nucleic acids of healthy rats; analysis of tumour regions in glioma-bearing rats suggested major nucleic acid modifications due to pMBRT.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Synchrotron-based infrared microspectroscopy study on the biomolecular impact of carbon minibeam radiation therapy on a mouse osteosarcoma cell line

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Cots Costa, Martina|||0009-0005-2861-6899
  • Gilbert, Cristele
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Seksek, Olivier|||0000-0002-3053-3022
  • Graeff, Christian|||0000-0002-5296-7649
  • Sokol, Olga|||0000-0003-3664-7538
  • Tinganelli, Walter|||0000-0003-0844-7272
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
Carbon minibeam radiation therapy (CMBRT) is a novel oncology treatment modality that combines the superior radiobiological properties of carbon ions with the remarkable tissue-sparing effects of spatial dose fractionation. Nevertheless, the differential biological mechanisms that CMBRT activates are not fully understood. To shed further light on such biomolecular processes, this study analysed the impact of CMBRT on LM8 osteosarcoma cells using synchrotron-based infrared microspectroscopy (SR-FTIRM). Samples were subjected to conventional carbon RT (CBB) and CMBRT at GSI (Germany). RT-treated cells underwent SR-FTIRM evaluations at ALBA Synchrotron (Spain) at 24 h post-RT. Principal component analysis (PCA) uncovered the main spectral differences between the treatment modalities, revealing that the IR signatures of CMBRT-treated samples were the most dissimilar from Control cells. Modifications of IR peaks attributed to α-helical and β-sheet protein sub-structures were consistent with the alterations of the Amide I spectral band due to CMBRT (assessed via curve-fitting analysis), suggesting enhanced protein oxidation. Conformational alterations in the sugar-phosphate backbone of nucleic acids might also have resulted from further oxidative damage due to CMBRT. Additionally, CMBRT led to greater alterations of methylene and methyl bands compared to CBB, which may have been caused by free radical attacks. Spectral signatures in the CMBRT valleys differed from those in the CMBRT peaks, suggesting distinct biomolecular mechanisms involved in these two dose regions. Comparison with proton and neon irradiations revealed common IR features affected by MBRT modalities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Potential Renewed Use of Very Heavy Ions for Therapy, Neon Minibeam Radiation Therapy

  • Prezado, Yolanda|||0000-0001-5957-2327
  • Hirayama, Ryochi
  • Matsufuji, Naruhiro
  • Inaniwa, Taku
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Seksek, Olivier|||0000-0002-3053-3022
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Koike, Sachiko
  • Labiod, Dalila
  • Pouzoulet, Frederic
  • Polledo, Laura
  • Warfving, Nils
  • Liens, Aléthéa
  • Bergs, Judith|||0000-0003-2497-3248
  • Shimokawa, Takashi|||0000-0001-6549-9277
The treatment of hypoxic tumours continues to be one of the main challenges for radiation therapy. Minibeam radiation therapy (MBRT) shows a highly promising reduction of to-xicity in normal tissue, so that very heavy ions, such as Neon (Ne) or Argon (Ar), with extremely high LET, might become applicable to clinical situations. The high LET in the target would be unrivalled to overcome hypoxia, while MBRT might limit the side effects normally preventing the use of those heavy ions in a conventional radiotherapeutic setting. The work reported in this manuscript is the first experimental proof of the remarkable reduction of normal tissue (skin) toxicities after Ne MBRT irradiations as compared to conventional Ne irradiations. This result might allow for a renewed use of very heavy ions for cancer therapy. (1) Background: among all types of radiation, very heavy ions, such as Neon (Ne) or Argon (Ar), are the optimum candidates for hypoxic tumor treatments due to their reduced oxygen enhancement effect. However, their pioneering clinical use in the 1970s was halted due to severe side effects. The aim of this work was to provide a first proof that the combination of very heavy ions with minibeam radiation therapy leads to a minimization of toxicities and, thus, opening the door for a renewed use of heavy ions for therapy; (2) Methods: mouse legs were irradiated with either Ne MBRT or Ne broad beams at the same average dose. Skin toxicity was scored for a period of four weeks. Histopathology evaluations were carried out at the end of the study; (3) Results: a significant difference in toxicity was observed between the two irradiated groups. While severe da-mage, including necrosis, was observed in the broad beam group, only light to mild erythema was present in the MBRT group; (4) Conclusion: Ne MBRT is significantly better tolerated than conventional broad beam irradiations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Medicated scaffolds prepared with Hydroxyapatite/Streptomycin nanoparticles encapsulated into Polylactide microfibers

  • Kadkhodaie-Elyaderani, Amirmajid|||0000-0002-2071-1227
  • de Lama-Odría, Maria del Carmen|||0000-0002-5076-8312
  • Rivas, Manuel
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Puiggalí, Jordi|||0000-0002-0640-4474
  • del Valle, Luis J.|||0000-0001-9916-1741
The preparation, characterization, and controlled release of hydroxyapatite (HAp) nanoparticles loaded with streptomycin (STR) was studied. These nanoparticles are highly appropriate for the treatment of bacterial infections and are also promising for the treatment of cancer cells. The analyses involved scanning electron microscopy, dynamic light scattering (DLS) and Z-potential measurements, as well as infrared spectroscopy and X-ray diffraction. Both amorphous (ACP) and crystalline (cHAp) hydroxyapatite nanoparticles were considered since they differ in their release behavior (faster and slower for amorphous and crystalline particles, respectively). The encapsulated nanoparticles were finally incorporated into biodegradable and biocompatible polylactide (PLA) scaffolds. The STR load was carried out following different pathways during the synthesis/precipitation of the nanoparticles (i.e., nucleation steps) and also by simple adsorption once the nanoparticles were formed. The loaded nanoparticles were biocompatible according to the study of the cytotoxicity of extracts using different cell lines. FTIR microspectroscopy was also employed to evaluate the cytotoxic effect on cancer cell lines of nanoparticles internalized by endocytosis. The results were promising when amorphous nanoparticles were employed. The nanoparticles loaded with STR increased their size and changed their superficial negative charge to positive. The nanoparticles' crystallinity decreased, with the consequence that their crystal sizes reduced, when STR was incorporated into their structure. STR maintained its antibacterial activity, although it was reduced during the adsorption into the nanoparticles formed. The STR release was faster from the amorphous ACP nanoparticles and slower from the crystalline cHAp nanoparticles. However, in both cases, the STR release was slower when incorporated in calcium and phosphate during the synthesis. The biocompatibility of these nanoparticles was assayed by two approximations. When extracts from the nanoparticles were evaluated in cultures of cell lines, no cytotoxic damage was observed at concentrations of less than 10 mg/mL. This demonstrated their biocompatibility. Another experiment using FTIR microspectroscopy evaluated the cytotoxic effect of nanoparticles internalized by endocytosis in cancer cells. The results demonstrated slight damage to the biomacromolecules when the cells were treated with ACP nanoparticles. Both ACP and cHAp nanoparticles were efficiently encapsulated in PLA electrospun matrices, providing functionality and bioactive properties.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Simulation and experimental verification of ambient neutron doses in a pencil beam scanning proton therapy room as a function of treatment plan parameters

  • Van Hoey, Olivier
  • Stolarczyk, Liliana
  • Lillhök, Jan
  • Eliasson, Linda
  • Mojzeszek, Natalia
  • Liszka, Malgorzata
  • Alkhiat, Ali
  • Mares, Vladimir
  • Trompier, François
  • Trinkl, Sebastian
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Romero-Expósito, Maite
  • Domingo, Carles|||0000-0002-8480-692X
  • Ploc, Ondrej
  • Harrison, Roger
  • Olko, Pawel
Out-of-field patient doses in proton therapy are dominated by neutrons. Currently, they are not taken into account by treatment planning systems. There is an increasing need to include out-of-field doses in the dose calculation, especially when treating children, pregnant patients, and patients with implants. In response to this demand, this work presents the first steps towards a tool for the prediction of out-of-field neutron doses in pencil beam scanning proton therapy facilities. As a first step, a general Monte Carlo radiation transport model for simulation of out-of-field neutron doses was set up and successfully verified by comparison of simulated and measured ambient neutron dose equivalent and neutron fluence energy spectra around a solid water phantom irradiated with a variation of different treatment plan parameters. Simulations with the verified model enabled a detailed study of the variation of the neutron ambient dose equivalent with field size, range, modulation width, use of a range shifter, and position inside the treatment room. For future work, it is planned to use this verified model to simulate out-of-field neutron doses inside the phantom and to verify the simulation results by comparison with previous in-phantom measurement campaigns. Eventually, these verified simulations will be used to build a library and a corresponding tool to allow assessment of out-of-field neutron doses at pencil beam scanning proton therapy facilities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neutron Radiation Dose Measurements in a Scanning Proton Therapy Room, Can Parents Remain Near Their Children During Treatment?

  • Mares, Vladimir
  • Farah, Jad
  • De Saint-Hubert, Marijke
  • Domański, Szymon
  • Domingo, Carles|||0000-0002-8480-692X
  • Dommert, Martin
  • Kłodowska, Magdalena
  • Krzempek, Katarzyna
  • Kuć, Michal
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Michaś, Edyta
  • Mojżeszek, Natalia
  • Murawski, Łukasz
  • Ploc, Ondrej
  • Romero-Expósito, Maite
  • Tisi, Marco
  • Trompier, François
  • Van Hoey, Olivier
  • Van Ryckeghem, Laurent
  • Wielunski, Marek
  • Harrison, Roger M.
  • Stolarczyk, Liliana
  • Olko, Pawel
Purpose: This study aims to characterize the neutron radiation field inside a scanning proton therapy treatment room including the impact of different pediatric patient sizes. Materials and Methods: Working Group 9 of the European Radiation Dosimetry Group (EURADOS) has performed a comprehensive measurement campaign to measure neutron ambient dose equivalent, H*(10), at eight different positions around 1-, 5-, and 10-year-old pediatric anthropomorphic phantoms irradiated with a simulated brain tumor treatment. Several active detector systems were used. Results: The neutron dose mapping within the gantry room showed that H*(10) values significantly decreased with distance and angular deviation with respect to the beam axis. A maximum value of about 19.5 µSv/Gy was measured along the beam axis at 1 m from the isocenter for a 10-year-old pediatric phantom at 270° gantry angle. A minimum value of 0.1 µSv/Gy was measured at a distance of 2.25 m perpendicular to the beam axis for a 1-year-old pediatric phantom at 140° gantry angle. The H*(10) dependence on the size of the pediatric patient was observed. At 270° gantry position, the measured neutron H*(10) values for the 10-year-old pediatric phantom were up to 20% higher than those measured for the 5-year-old and up to 410% higher than for the 1-year-old phantom, respectively. Conclusions: Using active neutron detectors, secondary neutron mapping was performed to characterize the neutron field generated during proton therapy of pediatric patients. It is shown that the neutron ambient dose equivalent H*(10) significantly decreases with distance and angle with respect to the beam axis. It is reported that the total neutron exposure of a person staying at a position perpendicular to the beam axis at a distance greater than 2 m from the isocenter remains well below the dose limit of 1 mSv per year for the general public (recommended by the International Commission on Radiological Protection) during the entire treatment course with a target dose of up to 60 Gy. This comprehensive analysis is key for general neutron shielding issues, for example, the safe operation of anesthetic equipment. However, it also enables the evaluation of whether it is safe for parents to remain near their children during treatment to bring them comfort. Currently, radiation protection protocols prohibit the occupancy of the treatment room during beam delivery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application

  • Guesdon-Vennerie, Alban
  • Couvreur, Patrick
  • Ali, Fatoumia
  • Pouzoulet, Fréderic
  • Roulin, Christophe
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Bernadat, Guillaume
  • Legrand, François-Xavier|||0000-0002-7271-7284
  • Bourgaux, Claudie
  • Mazars, Cyril Lucien
  • Marco, Sergio|||0000-0002-8173-4107
  • Trépout, Sylvain|||0000-0002-5822-407X
  • Mura, Simona
  • Mériaux, Sébastien|||0000-0001-7430-8348
  • Bort, Guillaume
Electromagnetic radiation-triggered therapeutic effect has attracted a great interest over the last 50 years. However, translation to clinical applications of photoactive molecular systems developed to date is dramatically limited, mainly because their activation requires excitation by low-energy photons from the ultraviolet to near infra-red range, preventing any activation deeper than few millimetres under the skin. Herein we conceive a strategy for photosensitive-system activation potentially adapted to biological tissues without any restriction in depth. High-energy stimuli, such as those employed for radiotherapy, are used to carry energy while molecular activation is provided by local energy conversion. This concept is applied to azobenzene, one of the most established photoswitches, to build a radioswitch. The radiation-responsive molecular system developed is used to trigger cytotoxic effect on cancer cells upon gamma-ray irradiation. This breakthrough activation concept is expected to expand the scope of applications of photosensitive systems and paves the way towards the development of original therapeutic approaches.